Emilie Alirol, STI Project Leader, GARDP
Emilie Alirol started to work with DNDi in August 2016, joining the Global Antibiotics Research and Development Partnership (GARDP) as a Project Advisor. In January 2017 she transitioned to a Senior Clinical Trial Manager position, working on both the Sexually Transmitted Infections (STIs) and Neonatal sepsis programs. Prior to this, she worked as Clinical Trial Manager of an MSF-sponsored trial on Multi-Drug Resistant Tuberculosis (MDR-TB).
Emilie obtained her PhD in molecular biology from the University of Geneva in 2006. She also holds a PG diploma in Epidemiology from the London School of Hygiene and Tropical Medicine (LSHTM). She started her career as a Clinical Research Scientist with the Geneva University Hospitals, where she focused on infectious diseases research. She has been involved in both therapeutic and diagnostic studies, and has managed several investigator-initiated trials, from phase 2 to 4. Since 2011 Emilie has also been engaged in training and education on clinical trials. She set up two post-graduate programmes at the University of Geneva: the DAS in Management of Clinical Trials and the MAS in Drug Discovery and Clinical Development.
Emilie has been an Ethics Committee member since 2010 and she is currently the vice chair of the WHO Research Ethics Review Committee.